Yesica Llimpe Mitma de Barrón
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yesica Llimpe Mitma de Barrón has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Heli Jaime Barrón Pastor
Molecular Medicine Research and Teaching Group (MEDMOL), Faculty of Medicine, Universidad Nacional Mayor de San Marcos, Lima 15081, Peru
6 shared publications - Doris Huerta-Canales
Molecular Medicine Research and Teaching Group (MEDMOL), Faculty of Medicine, Universidad Nacional Mayor de San Marcos, Lima 15081, Peru
3 shared publications - Jaeson Calla
Department of Pediatrics, University of California, San Diego
2 shared publications - Maria Bertha Paredes Pérez
Pediatric Emergency Hospital, MINSA, Lima, Peru
2 shared publications - Mario Monteghirfo-Gomero
Molecular Medicine Research and Teaching Group (MEDMOL), Faculty of Medicine, Universidad Nacional Mayor de San Marcos, Lima 15081, Peru
2 shared publications Abelardo Arias
Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru
1 shared publication
Latest Publications
- Open Access
Genotypic Characterization and Detection of CTX-M Groups 1, 2, and 9, and Antibiotic Susceptibility Profiles in Clinical Escherichia coli Isolates from a Pediatric Hospital in Lima, Peru
An increasing frequency of CTX-M-type extended-spectrum β-lactamase (ESBL)-producing Escherichia coli has been documented among pediatric infections in recent decades. This study aimed to analyze the antibiotic susceptibility profiles of ESBL-producing and non-ESBL-producing E. coli isolates, to detect CTX-M groups 1, 2, and 9 among ESBL producers, and to assess the clonal relationships between both groups in pediatric patients. A total of 124 E. coli isolates were recovered from clinical specimens (urine, stool, peritoneal fluid, and tracheal aspirates) collected between April and September 2025 at the Pediatric Emergency Hospital (PEH), Lima, Peru. CTX-M groups were detected by multiplex Polymerase Chain Reaction (mPCR), and clonal relationships were assessed by BOX-PCR. ESBL production was identified in 27.4% of isolates, significantly more frequent in urine samples (p < 0.05) and associated with multidrug-resistant (MDR) or extensively drug-resistant (XDR) profiles (p < 0.001). CTX-M group 1 predominated among ESBL producers (91.3%), while groups 2 and 9 were sporadic (2.9% each). BOX-PCR revealed high genetic heterogeneity, resolving 113 patterns (Simpson’s Index of Discrimination = 0.9986) and 31 ESBL-associated clones. These findings indicate that ESBL-producing E. coli dissemination in this setting is driven by diverse lineages rather than a dominant clone, highlighting the need for continued resistance surveillance.
Open AccessGenotypic Characterization and Detection of CTX-M Groups 1, 2, and 9, and Antibiotic Susceptibility Profiles in Clinical Escherichia coli Isolates from a Pediatric Hospital in Lima, Peru
An increasing frequency of CTX-M-type extended-spectrum β-lactamase (ESBL)-producing Escherichia coli has been documented among pediatric infections in recent decades. This study aimed to analyze the antibiotic susceptibility profiles of ESBL-producing and non-ESBL-producing E. coli isolates, to detect CTX-M groups 1, 2, and 9 among ESBL producers, and to assess the clonal relationships between both groups in pediatric patients. A total of 124 E. coli isolates were recovered from clinical specimens (urine, stool, peritoneal fluid, and tracheal aspirates) collected between April and September 2025 at the Pediatric Emergency Hospital (PEH), Lima, Peru. CTX-M groups were detected by multiplex Polymerase Chain Reaction (mPCR), and clonal relationships were assessed by BOX-PCR. ESBL production was identified in 27.4% of isolates, significantly more frequent in urine samples (p < 0.05) and associated with multidrug-resistant (MDR) or extensively drug-resistant (XDR) profiles (p < 0.001). CTX-M group 1 predominated among ESBL producers (91.3%), while groups 2 and 9 were sporadic (2.9% each). BOX-PCR revealed high genetic heterogeneity, resolving 113 patterns (Simpson’s Index of Discrimination = 0.9986) and 31 ESBL-associated clones. These findings indicate that ESBL-producing E. coli dissemination in this setting is driven by diverse lineages rather than a dominant clone, highlighting the need for continued resistance surveillance.
- Open Access
- 7 March 2026
- Published by Elsevier in Environmental Challenges
- Vol. 23
Genotoxicity and cytotoxicity evaluation of waters from sub–basins of the Negro River in Ancash–Peru in biological models of Allium cepa and Vicia faba
- 7 March 2026
- Published by Elsevier in Environmental Challenges
- Vol. 23
Open AccessGenotoxicity and cytotoxicity evaluation of waters from sub–basins of the Negro River in Ancash–Peru in biological models of Allium cepa and Vicia faba
- Open Access
- 3 March 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (3) , e0341525
Whole-genome analysis of extensively drug-resistant Acinetobacter baumannii isolates from a Peruvian tertiary hospital reveals the emergence of OXA-23-producing ST79 and ST1079 clones
Acinetobacter baumannii is a leading cause of extensively drug-resistant (XDR) infections in intensive care units (ICUs), with global concern due to its resistance to nearly all antimicrobials. In 2024, the WHO reaffirmed carbapenem-resistant A. baumannii as a critical-priority pathogen. In Peru, over 97% of clinical A. baumannii isolates are carbapenem non-susceptible, yet the genomic features of local strains remain poorly characterized. We performed whole-genome sequencing of 19 XDR A. baumannii isolates collected from ICU patients at Hospital Nacional Dos de Mayo (Lima, Peru) between May 2023 and September 2024. Genomes were analyzed for sequence types (ST), capsular (KL) and lipooligosaccharide (OCL) loci, virulence and resistance genes, and phylogenetic relatedness. All isolates were XDR but remained susceptible to colistin. Fourteen isolates belonged to ST2, forming two closely related subgroups carrying KL2 or KL9 and OCL1, with low SNP distances, suggesting recent clonal expansion. These ST2 genomes lacked bla OXA-23 but carried bla OXA-72 . Two isolates were assigned to ST79, harboring KL13/OCL10 and bla OXA-23 , representing the first report of this resistance gene in Peruvian ST79 strains. Three isolates belonged to ST1079, forming a tight Peruvian clade genetically distant from public ST1079 genomes; all carried KL107/OCL3 and bla OXA-23 , indicating possible local emergence. Our study revealed the emergence in Peru of XDR A. baumannii lineages ST79 and ST1079 harboring bla OXA-23 and the spread of high-risk ST2 clones carrying bla OXA-72 , underscoring the need for enhanced genomic surveillance and targeted infection-control measures. IMPORTANCE: A. baumannii is one of the most problematic hospital pathogens worldwide, often resistant to nearly all available antibiotics. In Peru, the proportion of carbapenem-resistant isolates is among the highest reported globally, yet their genetic background has remained largely unknown. This study provides the first genomic and phylogenomic insight into XDR A. baumannii from a major Peruvian hospital, revealing the spread of high-risk clones belonging to sequence type 2 carrying the OXA-72 carbapenemase, and the emergence of two additional lineages, sequence type 79 and sequence type 1079, both producing OXA-23. These findings demonstrate that multiple resistant lineages are established in Peru, highlighting the urgent need to implement genomic surveillance and infection control measures. Understanding the diversity and dynamics of these lineages is critical to limit their further spread and to guide public health responses in South America.
- 3 March 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (3) , e0341525
Open AccessWhole-genome analysis of extensively drug-resistant Acinetobacter baumannii isolates from a Peruvian tertiary hospital reveals the emergence of OXA-23-producing ST79 and ST1079 clones
Acinetobacter baumannii is a leading cause of extensively drug-resistant (XDR) infections in intensive care units (ICUs), with global concern due to its resistance to nearly all antimicrobials. In 2024, the WHO reaffirmed carbapenem-resistant A. baumannii as a critical-priority pathogen. In Peru, over 97% of clinical A. baumannii isolates are carbapenem non-susceptible, yet the genomic features of local strains remain poorly characterized. We performed whole-genome sequencing of 19 XDR A. baumannii isolates collected from ICU patients at Hospital Nacional Dos de Mayo (Lima, Peru) between May 2023 and September 2024. Genomes were analyzed for sequence types (ST), capsular (KL) and lipooligosaccharide (OCL) loci, virulence and resistance genes, and phylogenetic relatedness. All isolates were XDR but remained susceptible to colistin. Fourteen isolates belonged to ST2, forming two closely related subgroups carrying KL2 or KL9 and OCL1, with low SNP distances, suggesting recent clonal expansion. These ST2 genomes lacked bla OXA-23 but carried bla OXA-72 . Two isolates were assigned to ST79, harboring KL13/OCL10 and bla OXA-23 , representing the first report of this resistance gene in Peruvian ST79 strains. Three isolates belonged to ST1079, forming a tight Peruvian clade genetically distant from public ST1079 genomes; all carried KL107/OCL3 and bla OXA-23 , indicating possible local emergence. Our study revealed the emergence in Peru of XDR A. baumannii lineages ST79 and ST1079 harboring bla OXA-23 and the spread of high-risk ST2 clones carrying bla OXA-72 , underscoring the need for enhanced genomic surveillance and targeted infection-control measures. IMPORTANCE: A. baumannii is one of the most problematic hospital pathogens worldwide, often resistant to nearly all available antibiotics. In Peru, the proportion of carbapenem-resistant isolates is among the highest reported globally, yet their genetic background has remained largely unknown. This study provides the first genomic and phylogenomic insight into XDR A. baumannii from a major Peruvian hospital, revealing the spread of high-risk clones belonging to sequence type 2 carrying the OXA-72 carbapenemase, and the emergence of two additional lineages, sequence type 79 and sequence type 1079, both producing OXA-23. These findings demonstrate that multiple resistant lineages are established in Peru, highlighting the urgent need to implement genomic surveillance and infection control measures. Understanding the diversity and dynamics of these lineages is critical to limit their further spread and to guide public health responses in South America.
- Open Access
Transcriptome-Based Survival Analysis Identifies MAP4K4 as a Prognostic Marker in Gastric Cancer with Microsatellite Instability
Background/Objectives: Gastric cancer (GC) is a highly aggressive malignancy with diverse molecular subtypes. While microsatellite instability (MSI) GC generally carries a favorable prognosis, a subset of patients experiences poor outcomes, highlighting the need for refined prognostic markers. Methods: This study utilized transcriptomic and clinical data from two independent cohorts, The Cancer Genome Atlas (TCGA) and the Asian Cancer Research Group (ACRG), to identify novel prognostic genes in MSI-GC. Results: Through rigorous survival analysis, we identified high MAP4K4 expression (MAP4K4high) as an independent and robust predictor of poor overall survival (OS) and disease-free survival (DFS) specifically within the MSI-GC subtype. MAP4K4high was associated with increased hazard ratios for both OS and DFS in both cohorts, even after adjusting for clinicopathological factors. Further analysis revealed that MAP4K4high MSI-GC tumors exhibit a distinct molecular profile characterized by increased extracellular matrix remodeling, epithelial–mesenchymal transition, and a microenvironment enriched in monocytes and cancer-associated fibroblasts (CAFs). Notably, a subgroup of MSI-GC patients with a CIN-like phenotype and high MAP4K4 expression exhibited particularly dismal outcomes. Conclusions: Our findings establish MAP4K4 as a promising prognostic biomarker for risk stratification in MSI-GC and suggest its potential role in driving aggressive tumor behavior through modulation of the tumor microenvironment.
Open AccessTranscriptome-Based Survival Analysis Identifies MAP4K4 as a Prognostic Marker in Gastric Cancer with Microsatellite Instability
Background/Objectives: Gastric cancer (GC) is a highly aggressive malignancy with diverse molecular subtypes. While microsatellite instability (MSI) GC generally carries a favorable prognosis, a subset of patients experiences poor outcomes, highlighting the need for refined prognostic markers. Methods: This study utilized transcriptomic and clinical data from two independent cohorts, The Cancer Genome Atlas (TCGA) and the Asian Cancer Research Group (ACRG), to identify novel prognostic genes in MSI-GC. Results: Through rigorous survival analysis, we identified high MAP4K4 expression (MAP4K4high) as an independent and robust predictor of poor overall survival (OS) and disease-free survival (DFS) specifically within the MSI-GC subtype. MAP4K4high was associated with increased hazard ratios for both OS and DFS in both cohorts, even after adjusting for clinicopathological factors. Further analysis revealed that MAP4K4high MSI-GC tumors exhibit a distinct molecular profile characterized by increased extracellular matrix remodeling, epithelial–mesenchymal transition, and a microenvironment enriched in monocytes and cancer-associated fibroblasts (CAFs). Notably, a subgroup of MSI-GC patients with a CIN-like phenotype and high MAP4K4 expression exhibited particularly dismal outcomes. Conclusions: Our findings establish MAP4K4 as a promising prognostic biomarker for risk stratification in MSI-GC and suggest its potential role in driving aggressive tumor behavior through modulation of the tumor microenvironment.
- Open Access
- 1 January 2025
- Published by XMLink in Infection & Chemotherapy
- Vol. 57 (1) , 93-101
Phylogenetic Analysis of Escherichia coli according to Phenotypic Resistance in Urinary Tract Infections in Children, Lima, Peru
Farfan AB, et al. Infect Chemother. 2025 Jan;57:e2. https://doi.org/10.3947/ic.2024.0101
- 1 January 2025
- Published by XMLink in Infection & Chemotherapy
- Vol. 57 (1) , 93-101
Open AccessPhylogenetic Analysis of Escherichia coli according to Phenotypic Resistance in Urinary Tract Infections in Children, Lima, Peru
Farfan AB, et al. Infect Chemother. 2025 Jan;57:e2. https://doi.org/10.3947/ic.2024.0101
- Open Access
- 20 December 2024
- Published by Universidad Nacional Mayor de San Marcos, Vicerectorado de Investigacion in Revista de Investigaciones Veterinarias del Perú
- Vol. 35 (6) , e29633
Resistencia antibiótica en cepas de Campylobacter spp aisladas de carnes y vísceras para consumo humano: Una revisión narrativa
El estudio presenta una revisión narrativa sobre la resistencia antimicrobiana en cepas de Campylobacter spp aisladas de canes y vísceras de animales destinados al consumo humano. Se revisaron 1067 artículos sobre resistencia a antibióticos en cepas de Campylobacter spp publicados entre 2012 a 2022 y recuperados de bases de datos como PubMed y SciELO de las que se seleccionaron 26 artículos. La prevalencia de Campylobacter spp varió según el tipo de muestra, país y especie, siendo más alta en carne cruda de aves (pollo y pavo). Los estudios revelaron altas frecuencias de resistencia en quinolonas, fluoroquinolonas, tetraciclinas y otros antibióticos. La resistencia a macrólidos, aminoglucósidos y algunos antibióticos fue más baja, con excepciones en aislamientos de bovinos y cerdos. Se concluye que hay altas tasas de resistencia en cepas de Campylobacter spp de carnes de aves de corral en la última década, especialmente en pollos de expendio en mercado.
- 20 December 2024
- Published by Universidad Nacional Mayor de San Marcos, Vicerectorado de Investigacion in Revista de Investigaciones Veterinarias del Perú
- Vol. 35 (6) , e29633
Open AccessResistencia antibiótica en cepas de Campylobacter spp aisladas de carnes y vísceras para consumo humano: Una revisión narrativa
El estudio presenta una revisión narrativa sobre la resistencia antimicrobiana en cepas de Campylobacter spp aisladas de canes y vísceras de animales destinados al consumo humano. Se revisaron 1067 artículos sobre resistencia a antibióticos en cepas de Campylobacter spp publicados entre 2012 a 2022 y recuperados de bases de datos como PubMed y SciELO de las que se seleccionaron 26 artículos. La prevalencia de Campylobacter spp varió según el tipo de muestra, país y especie, siendo más alta en carne cruda de aves (pollo y pavo). Los estudios revelaron altas frecuencias de resistencia en quinolonas, fluoroquinolonas, tetraciclinas y otros antibióticos. La resistencia a macrólidos, aminoglucósidos y algunos antibióticos fue más baja, con excepciones en aislamientos de bovinos y cerdos. Se concluye que hay altas tasas de resistencia en cepas de Campylobacter spp de carnes de aves de corral en la última década, especialmente en pollos de expendio en mercado.
- Open Access
- 30 September 2023
- Published by Instituto de Investigacion en Ciencias Biomedicas in Revista de la Facultad de Medicina Humana
- Vol. 23 (3) , 115-121
Cytogenetic findings and maternal age in patients with Down syndrome in a pediatric referral hospital from Peru
Introduction: Down syndrome is a congenital disorder caused by a total or partial trisomy of chromosome 21 and is considered the most common genetic cause of congenital malformations and intellectual disability. The objective of this study was to describe the cytogenetic alterations of patients with Down syndrome and their relationship with maternal age. Methods: Cross-sectional, descriptive-analytical study. 436 patients with Down syndrome admitted to the Instituto Nacional de Salud del Niño during the 2017-2019 period were included. The variables analyzed were: cytogenetic diagnosis and maternal age. Results: It was found that 99,3% (n=433) of patients presented some type of cytogenetic alteration and three patients presented a normal karyotype. The age of the patients at the time of sampling was between 0,03 and 17 years, the male/female ratio was 1.2:1. The most frequent cytogenetic alteration was free trisomy 21 (94,7%), followed by Robertsonian translocation (n=16) and mosaicism (n=6). In the case of maternal age, a median of 37 years was found (range: 13-47). Conclusions: Free trisomy 21 is the most common cytogenetic condition in Down syndrome; however, the Robertsonian translocation and mosaicisms were more frequent in patients whose mothers were les than 35 years old, suggesting that there are other risk factors than advanced maternal age in this group. Keywords: Down syndrome, cytogenetic analysis, maternal age, pediatrics.
- 30 September 2023
- Published by Instituto de Investigacion en Ciencias Biomedicas in Revista de la Facultad de Medicina Humana
- Vol. 23 (3) , 115-121
Open AccessCytogenetic findings and maternal age in patients with Down syndrome in a pediatric referral hospital from Peru
Introduction: Down syndrome is a congenital disorder caused by a total or partial trisomy of chromosome 21 and is considered the most common genetic cause of congenital malformations and intellectual disability. The objective of this study was to describe the cytogenetic alterations of patients with Down syndrome and their relationship with maternal age. Methods: Cross-sectional, descriptive-analytical study. 436 patients with Down syndrome admitted to the Instituto Nacional de Salud del Niño during the 2017-2019 period were included. The variables analyzed were: cytogenetic diagnosis and maternal age. Results: It was found that 99,3% (n=433) of patients presented some type of cytogenetic alteration and three patients presented a normal karyotype. The age of the patients at the time of sampling was between 0,03 and 17 years, the male/female ratio was 1.2:1. The most frequent cytogenetic alteration was free trisomy 21 (94,7%), followed by Robertsonian translocation (n=16) and mosaicism (n=6). In the case of maternal age, a median of 37 years was found (range: 13-47). Conclusions: Free trisomy 21 is the most common cytogenetic condition in Down syndrome; however, the Robertsonian translocation and mosaicisms were more frequent in patients whose mothers were les than 35 years old, suggesting that there are other risk factors than advanced maternal age in this group. Keywords: Down syndrome, cytogenetic analysis, maternal age, pediatrics.
- Open Access
- 29 June 2021
- Published by Instituto Nacional de Salud (Colombia) in Biomédica
- Vol. 41 (2) , 302-313
Grupos de riesgo citogenético de leucemia mieloide aguda pediátrica a partir del análisis de supervivencia en un hospital de referencia para cáncer en Perú
Introducción. La leucemia mieloide aguda es una neoplasia heterogénea caracterizada por la proliferación de células mieloides inmaduras. El análisis citogenético ha revelado la presencia de aberraciones cromosómicas de importancia en el pronóstico del paciente.Objetivo. Determinar los grupos de riesgo citogenético de pacientes pediátricos con leucemia mieloide aguda a partir de la supervivencia global.Materiales y métodos. Se hizo un estudio observacional de corte transversal. Se incluyeron los registros clínicos de los pacientes pediátricos con diagnóstico de leucemia mieloide aguda de novo admitidos en el Instituto Nacional de Enfermedades Neoplásicas entre el 2001 y el 2011 y sometidos a análisis citogenético de médula ósea. Los grupos de riesgo citogenético se establecieron según los criterios del Medical Research Council. Las curvas de supervivencia global se elaboraron con el método de Kaplan-Meier y se compararon mediante la prueba de Mantel-Cox y una regresión de Cox, utilizando el programa R, versión 3.3.2.Resultados. Se incluyeron 130 pacientes, 68 varones (52,3 %) y 62 mujeres (47,7 %), mayoritariamente del subtipo M2 (33 %). La edad promedio fue de 7,7 (rango de 0 a 15 años). Se observaron aberraciones cromosómicas en el 60,8 % y la más frecuente fue la traslocación t(8;21). Según el análisis de supervivencia global, se observaron dos grupos de riesgo citogenético: favorable y desfavorable.Conclusión. Se determinaron dos grupos de riesgo citogenético: alto (o desfavorable) y estándar (o favorable).
- 29 June 2021
- Published by Instituto Nacional de Salud (Colombia) in Biomédica
- Vol. 41 (2) , 302-313
Open AccessGrupos de riesgo citogenético de leucemia mieloide aguda pediátrica a partir del análisis de supervivencia en un hospital de referencia para cáncer en Perú
Introducción. La leucemia mieloide aguda es una neoplasia heterogénea caracterizada por la proliferación de células mieloides inmaduras. El análisis citogenético ha revelado la presencia de aberraciones cromosómicas de importancia en el pronóstico del paciente.Objetivo. Determinar los grupos de riesgo citogenético de pacientes pediátricos con leucemia mieloide aguda a partir de la supervivencia global.Materiales y métodos. Se hizo un estudio observacional de corte transversal. Se incluyeron los registros clínicos de los pacientes pediátricos con diagnóstico de leucemia mieloide aguda de novo admitidos en el Instituto Nacional de Enfermedades Neoplásicas entre el 2001 y el 2011 y sometidos a análisis citogenético de médula ósea. Los grupos de riesgo citogenético se establecieron según los criterios del Medical Research Council. Las curvas de supervivencia global se elaboraron con el método de Kaplan-Meier y se compararon mediante la prueba de Mantel-Cox y una regresión de Cox, utilizando el programa R, versión 3.3.2.Resultados. Se incluyeron 130 pacientes, 68 varones (52,3 %) y 62 mujeres (47,7 %), mayoritariamente del subtipo M2 (33 %). La edad promedio fue de 7,7 (rango de 0 a 15 años). Se observaron aberraciones cromosómicas en el 60,8 % y la más frecuente fue la traslocación t(8;21). Según el análisis de supervivencia global, se observaron dos grupos de riesgo citogenético: favorable y desfavorable.Conclusión. Se determinaron dos grupos de riesgo citogenético: alto (o desfavorable) y estándar (o favorable).
- Open Access
- 24 July 2019
- Published by Universidad de Manizales in Archivos de Medicina (Manizales)
- Vol. 19 (2)
Clasificación filogenética de Escherichia coli uropatógena y respuesta inmunometabólica en adultos mayores con infección urinaria en casas de reposo
Objetivos: Caracterizar la respuesta inmunometabólica en la orina de pacientes adultos mayores infectados con Escherichia coli uropatógena residentes en casas de reposo y determinar su frecuencia filogenética. Materiales y métodos: Estudio observacional descriptivo, en el cual se enrolaron 24 pacientes con infección del tracto urinario y 17 pacientes sin infección del tracto urinario. Se cuantificó el hierro y el TNF – α en orina por metodos espectrofotometricos, la capacidad antioxidante por ensayo ABTS+* y la determinación filogenética de E. coli por el método de Clermont. Resultados: La concentración de hierro, TNF – α y la capacidad antioxidante en la orina en pacientes con infección del tracto urinario los valores fueron de 175,40 mg/L, 70,11 pg/mL y 1229,75 mg/mL eq-VitC, mientras que en pacientes sin infección fue de 67,4 mg/L (p = 0,001), 87,16 pg/mL (p = 0,08) y 1069,14 mg/mL eq-VitC (p = 0,61) respectivamente. Además, se encontraron 11 E.coli pertenecientes al grupo B2 y 13 agrupados en no - B2 (A, B1, D y E). Conclusiones: Se evidencia una alta disponibilidad de hierro en la orina de los pacientes adulto mayores con infección del tracto urinario, lo cual estimula la proliferación bacteriana. Hay una elevada capacidad antioxidante en la orina de los pacientes con infección del tracto urinario y una mayor presencia clonal de E.coli de tipo no B2 en la orina de los pacientes residentes en casas de reposo.
- 24 July 2019
- Published by Universidad de Manizales in Archivos de Medicina (Manizales)
- Vol. 19 (2)
Open AccessClasificación filogenética de Escherichia coli uropatógena y respuesta inmunometabólica en adultos mayores con infección urinaria en casas de reposo
Objetivos: Caracterizar la respuesta inmunometabólica en la orina de pacientes adultos mayores infectados con Escherichia coli uropatógena residentes en casas de reposo y determinar su frecuencia filogenética. Materiales y métodos: Estudio observacional descriptivo, en el cual se enrolaron 24 pacientes con infección del tracto urinario y 17 pacientes sin infección del tracto urinario. Se cuantificó el hierro y el TNF – α en orina por metodos espectrofotometricos, la capacidad antioxidante por ensayo ABTS+* y la determinación filogenética de E. coli por el método de Clermont. Resultados: La concentración de hierro, TNF – α y la capacidad antioxidante en la orina en pacientes con infección del tracto urinario los valores fueron de 175,40 mg/L, 70,11 pg/mL y 1229,75 mg/mL eq-VitC, mientras que en pacientes sin infección fue de 67,4 mg/L (p = 0,001), 87,16 pg/mL (p = 0,08) y 1069,14 mg/mL eq-VitC (p = 0,61) respectivamente. Además, se encontraron 11 E.coli pertenecientes al grupo B2 y 13 agrupados en no - B2 (A, B1, D y E). Conclusiones: Se evidencia una alta disponibilidad de hierro en la orina de los pacientes adulto mayores con infección del tracto urinario, lo cual estimula la proliferación bacteriana. Hay una elevada capacidad antioxidante en la orina de los pacientes con infección del tracto urinario y una mayor presencia clonal de E.coli de tipo no B2 en la orina de los pacientes residentes en casas de reposo.
- Open Access
- 1 March 2013
- Published by FapUNIFESP (SciELO) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 30 (1) , 145-146
Leucemia mieloide aguda subtipo M2 con variante de la translocación t(8;21) y expresión AML1/ETO
- 1 March 2013
- Published by FapUNIFESP (SciELO) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 30 (1) , 145-146
Open AccessLeucemia mieloide aguda subtipo M2 con variante de la translocación t(8;21) y expresión AML1/ETO